26 Papers
120 Citations
J. Kim is an academic researcher from Princess Margaret Cancer Centre. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 6, co-authored 24 publications. Previous affiliations of J. Kim include Ontario Institute for Cancer Research & University of Toronto.
Chat about Author
Papers
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
Faiyaz Notta,Michelle Chan-Seng-Yue,Mathieu Lemire,Yang Li,Gavin W. Wilson,Ashton A. Connor,Robert E. Denroche,Sheng Ben Liang,Andrew M.K. Brown,J. Kim,J. Kim,Tao Wang,Jared T. Simpson,Jared T. Simpson,Timothy Beck,Ayelet Borgida,Nicholas Buchner,Dianne Chadwick,Sara Hafezi-Bakhtiari,Sara Hafezi-Bakhtiari,John E. Dick,John E. Dick,John E. Dick,Lawrence E. Heisler,Michael A. Hollingsworth,Emin Ibrahimov,Gun Ho Jang,Jeremy Johns,Lars G.T. Jorgensen,Calvin Law,Olga Ludkovski,Ilinca Lungu,Karen Ng,Danielle Pasternack,Gloria M. Petersen,Liran I. Shlush,Lee Timms,Ming-Sound Tsao,Ming-Sound Tsao,Julie M. Wilson,Christina K. Yung,George Zogopoulos,John M. S. Bartlett,Ludmil B. Alexandrov,Francisco X. Real,Sean P. Cleary,Michael H.A. Roehrl,John Douglas Mcpherson,John Douglas Mcpherson,Lincoln Stein,Lincoln Stein,Thomas J. Hudson,Thomas J. Hudson,Peter J. Campbell,Peter J. Campbell,Steven Gallinger,Steven Gallinger,Steven Gallinger +57 more
TL;DR: It is found that pancreatic cancer tumorigenesis is neither gradual nor follows the accepted mutation order, and changes in DNA copy number and their associated rearrangements in tumour-enriched genomes are tracked and challenged.
531
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
Michelle Chan-Seng-Yue,Michelle Chan-Seng-Yue,J. Kim,J. Kim,Gavin W. Wilson,Karen Ng,Eugenia Flores Figueroa,Grainne M. O'Kane,Grainne M. O'Kane,Ashton A. Connor,Robert E. Denroche,Robert C. Grant,Jessica McLeod,Julie M. Wilson,Gun Ho Jang,Amy Zhang,Anna Dodd,Sheng-Ben Liang,Ayelet Borgida,Dianne Chadwick,Sangeetha N Kalimuthu,Ilinca Lungu,John M. S. Bartlett,Paul M. Krzyzanowski,Vandana Sandhu,Hervé Tiriac,Hervé Tiriac,Hervé Tiriac,Fieke E. M. Froeling,Fieke E. M. Froeling,Fieke E. M. Froeling,Joanna M. Karasinska,James T. Topham,Daniel J. Renouf,David F. Schaeffer,Steven J.M. Jones,Marco A. Marra,Janessa Laskin,Runjan Chetty,Lincoln Stein,Lincoln Stein,George Zogopoulos,George Zogopoulos,Benjamin Haibe-Kains,Peter J. Campbell,Peter J. Campbell,David A. Tuveson,David A. Tuveson,Jennifer J. Knox,Jennifer J. Knox,Sandra Fischer,Sandra Fischer,Steven Gallinger,Faiyaz Notta,Faiyaz Notta,Faiyaz Notta +55 more
TL;DR: Whole-genome sequencing, transcriptome sequencing and single-cell analysis of primary and metastatic pancreatic adenocarcinoma identify molecular subtypes and intratumor heterogeneity, and support the premise that the constellation of genomic aberrations in the tumor gives rise to the molecular subtype.
513
Multiple Dysregulated Pathways in Nasopharyngeal Carcinoma Revealed by Gene Expression Profiling
Carlo Bastianutto,W. Shi,A. Li,Bayardo Perez-Ordonez,R. Ng,K.-Y. Chow,W. Zhang,Igor Jurisica,Andrew Bayley,J. Kim,Brian O'Sullivan,Fei-Fei Liu +11 more
TL;DR: Gene expression profiling was conducted using primary human nasopharyngeal carcinoma biopsy samples to improve the understanding of the molecular pathways defining NPC, and suggest survivin as a novel therapeutic target for NPC.
60
Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas
Robert J. Myerson,Michael C. Garofalo,I. El Naqa,Ross A. Abrams,P. Das,Leonard L. Gunderson,Theodore S. Hong,J. Kim,Christopher G. Willett,Lisa A. Kachnic +9 more
TL;DR: A Radiation Therapy Oncology Group (RTOG) atlas of the elective clinical target volume (CTV) definitions to be used for planning pelvic intensity-modulated radiotherapy (IMRT) for anal and rectal cancers is developed.
32
Outcomes by treatment modality in elderly patients with localized gastric and esophageal cancer.
Akina Natori,Bryan A. Chan,Hao-Wen Sim,Lucy Xiaolu Ma,Daniel Yokom,Eric Chen,G. Liu,Gail Darling,Carol Jane Swallow,Savtaj S. Brar,James Brierley,Jolie Ringash,Raimond Wong,J. Kim,Patrik Rogalla,Sara Hafezi-Bakhtiari,James Conner,Jennifer J. Knox,Elena Elimova,Raymond Woo-Jun Jang +19 more
TL;DR: Outcomes were better for patients who underwent surgery than for those who did not, and comprehensive geriatric assessment should be considered for patients 75 years of age and older with localized ge cancers.